Mohamed El‐Mesery

1.6k total citations
62 papers, 1.2k citations indexed

About

Mohamed El‐Mesery is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Mohamed El‐Mesery has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Epidemiology and 16 papers in Hepatology. Recurrent topics in Mohamed El‐Mesery's work include Cell death mechanisms and regulation (12 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Mohamed El‐Mesery is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (8 papers). Mohamed El‐Mesery collaborates with scholars based in Egypt, Germany and Saudi Arabia. Mohamed El‐Mesery's co-authors include Abdelaziz Elgaml, Amro El‐Karef, Mohammed El‐Mowafy, Laila A. Eissa, Mohamed E. Shaker, Hatem A. Salem, Mohammed M.H. Al-Gayyar, Abdalla M. El‐Mowafy, Mamdouh M. El‐Shishtawy and Emad Kandil and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Mohamed El‐Mesery

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed El‐Mesery Egypt 21 460 203 197 188 142 62 1.2k
Akshata Moghe United States 12 408 0.9× 90 0.4× 203 1.0× 88 0.5× 125 0.9× 30 952
Ting Zhu China 24 632 1.4× 376 1.9× 276 1.4× 99 0.5× 64 0.5× 81 1.7k
Rajgopal Govindarajan United States 26 883 1.9× 177 0.9× 197 1.0× 539 2.9× 55 0.4× 49 2.1k
Dragana Nikolić Italy 32 710 1.5× 64 0.3× 387 2.0× 74 0.4× 97 0.7× 78 2.6k
Yin Cai China 23 648 1.4× 72 0.4× 212 1.1× 118 0.6× 110 0.8× 84 1.4k
Cheng-Jeng Tai Taiwan 25 800 1.7× 35 0.2× 155 0.8× 330 1.8× 121 0.9× 92 1.9k
Livia Bianchi Italy 23 586 1.3× 40 0.2× 197 1.0× 213 1.1× 132 0.9× 35 1.7k
Hitoshi Ishizuka Japan 17 468 1.0× 114 0.6× 166 0.8× 500 2.7× 141 1.0× 56 1.4k
B. Kevin Park United Kingdom 25 786 1.7× 68 0.3× 267 1.4× 211 1.1× 163 1.1× 36 2.5k

Countries citing papers authored by Mohamed El‐Mesery

Since Specialization
Citations

This map shows the geographic impact of Mohamed El‐Mesery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed El‐Mesery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed El‐Mesery more than expected).

Fields of papers citing papers by Mohamed El‐Mesery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed El‐Mesery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed El‐Mesery. The network helps show where Mohamed El‐Mesery may publish in the future.

Co-authorship network of co-authors of Mohamed El‐Mesery

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed El‐Mesery. A scholar is included among the top collaborators of Mohamed El‐Mesery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed El‐Mesery. Mohamed El‐Mesery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Mesery, Mohamed, et al.. (2024). Non-canonical functions of BCL-2 family members in energy metabolism and necrotic cell death regulation. Cell Cycle. 23(21-24). 931–948.
2.
Shaker, Mohamed E., et al.. (2023). Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib. Frontiers in Pharmacology. 14. 1212771–1212771. 2 indexed citations
3.
4.
5.
El‐Mesery, Mohamed, et al.. (2022). Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(8). 1003–1016. 10 indexed citations
6.
Hamdy, Omar, et al.. (2022). Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: A randomized controlled clinical trial. Saudi Pharmaceutical Journal. 30(10). 1486–1496. 9 indexed citations
7.
El‐Mesery, Mohamed, et al.. (2021). Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients. Journal of Interferon & Cytokine Research. 41(2). 52–59. 8 indexed citations
8.
El‐Mesery, Mohamed, et al.. (2020). Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma. Tumor Biology. 42(4). 2904792107–2904792107. 6 indexed citations
9.
Toraih, Eman A., Rami M. Elshazli, Mohammad H. Hussein, et al.. (2020). Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and decision tree analysis. Journal of Medical Virology. 92(11). 2473–2488. 63 indexed citations
10.
Hamdy, Mona, et al.. (2020). Curcumin offsets PTZ-induced epilepsy: involving inhibition of apoptosis, wnt/β-catenin, and autophagy pathways. Egyptian Journal of Basic and Applied Sciences. 7(1). 240–251. 3 indexed citations
11.
Elshazli, Rami M., Eman A. Toraih, Abdelaziz Elgaml, et al.. (2020). Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS ONE. 15(8). e0238160–e0238160. 148 indexed citations
12.
Shaker, Mohamed E., Ahmed A. Shaaban, Mohamed El‐Shafey, & Mohamed El‐Mesery. (2020). The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies. Toxicology and Applied Pharmacology. 398. 115018–115018. 17 indexed citations
13.
El‐Hawary, Seham S., Ahmed M. Sayed, Rabab Mohammed, et al.. (2019). Bioactive Brominated Oxindole Alkaloids from the Red Sea Sponge Callyspongia siphonella. Marine Drugs. 17(8). 465–465. 48 indexed citations
14.
Hussein, Abdelaziz M., et al.. (2019). Effects of GLP-1 Receptor Activation on a Pentylenetetrazole—Kindling Rat Model. Brain Sciences. 9(5). 108–108. 19 indexed citations
15.
16.
17.
El‐Mesery, Mohamed, Alexander Kübler, Urs Müller‐Richter, et al.. (2017). The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent. PLoS ONE. 12(10). e0185720–e0185720. 8 indexed citations
18.
El‐Mesery, Mohamed, Axel Seher, Thorsten Stühmer, Daniela Siegmund, & Harald Wajant. (2014). MLN4924 sensitizes monocytes and maturing dendritic cells for TNF‐dependent and ‐independent necroptosis. British Journal of Pharmacology. 172(5). 1222–1236. 26 indexed citations
19.
El‐Mowafy, Abdalla M., et al.. (2010). Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling. Phytomedicine. 17(14). 1067–1075. 62 indexed citations
20.
El‐Mowafy, Abdalla M., et al.. (2010). Prominent Chemopreventive and Chemoenhancing Effects for Resveratrol: Unraveling Molecular Targets and the Role of C-Reactive Protein. Chemotherapy. 56(1). 60–65. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akshata Moghe Breakdown of academic impact, for papers by Ting Zhu Breakdown of academic impact, for papers by Rajgopal Govindarajan Breakdown of academic impact, for papers by Dragana Nikolić Breakdown of academic impact, for papers by Yin Cai Breakdown of academic impact, for papers by Cheng-Jeng Tai Breakdown of academic impact, for papers by Livia Bianchi Breakdown of academic impact, for papers by Hitoshi Ishizuka Breakdown of academic impact, for papers by B. Kevin Park
Rankless by CCL
2026